scorecard

You Searched For "moderna stock" and got 20 results


Sort By:


Business Insider Latest Story Image
1 min read

Moderna stock tumbles 21% as earnings show people aren't getting as many COVID shots

Moderna lowered its annual sales forecast as sales of its COVID-19 vaccine dropped by 37%, fueled b…

Kelly Cloonan   


Business Insider Latest Story Image
1 min read

Stock market today: Indexes tank as data paints a negative picture for the economy

Stock indexes tanked Thursday as new data shows jobless claims are on the rise while manufacturing …

Kelly Cloonan   


Business Insider Latest Story Image
1 min read

Moderna pops, then drops after it says booster shot increases protection against Omicron

A third dose of Moderna's booster vaccine resulted in a 37-fold increase in antibody protection aga…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue

The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Pandemic-related stocks from Zoom to Moderna jump as new coronavirus variant raises alarms and triggers lockdowns

The stock prices of vaccine makers Moderna and Pfizer surged Friday along with stay-at-home stocks …

Isabelle Lee   


Business Insider Latest Story Image
1 min read

Moderna extends 2-day gain to 32% after it says Omicron vaccine will be ready in early 2022

"If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Moderna and BioNTech plummet more than 15% following news of Merck's COVID-19 antiviral pill

The antiviral drug could put a dent into the uptake of COVID-19 vaccines, as countries still strugg…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Pfizer drops after issuing weaker 2022 outlook, dragging COVID-19 vaccine makers Moderna and Novavax down with it

The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expecta…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Moderna and Novavax pare losses after Supreme Court strikes down Biden's vaccine mandate for private employers

The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld …

Carla Mozée   


Business Insider Latest Story Image
1 min read

Moderna and Pfizer rebound after FDA authorizes third COVID-19 booster shot for immunocompromised

Year-to-date, shares of BioNTech, Moderna, and Pfizer have surged 357%, 275%, and 28%, respectively.

Matthew Fox   


Business Insider Latest Story Image
2 mins read

'From unreasonable to ridiculous': Here's why Moderna is set to fall 76%, according to Bank of America

"To justify $200 billion in value, one has to assume 1 to 1.5 billion doses of COVID-19 vaccine eac…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Moderna spikes 19% amid a flood of encouraging vaccine news, surpassing Merck in market value

Moderna, the almost 11 year old company that created a 95% effective pandemic ending vaccine in les…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Moderna spikes 11% to record highs after it is selected to be added to S&P 500

Alexion Therapeutics, which is set to be acquired by AstraZeneca, will be replaced by Moderna in th…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Billionaires and corporate execs have dumped $9 billion worth of stock this year amid the market's latest rally

Big-name investors have moved quickly to dump stock shares amid this year's rally, with the S&P 500…

Jennifer Sor   


Business Insider Latest Story Image
1 min read

Moderna soars 24% after the drug maker posts upbeat results from cancer vaccine trial

The pharma giant said combining its cancer vaccine with Merck's Keytruda therapy reduced patients' …

Phil Rosen   


Business Insider Latest Story Image
1 min read

Moderna and Pfizer shares climb after CDC calls for pause in use of J&J COVID-19 vaccine

The CDC's guidance to pause the use of J&J's COVID vaccine came following reports of 6 rare blood c…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Moderna, BioNTech tumble 19% amid report the EU is looking into COVID vaccine side effects

The EU's drug regulator is looking at reports about skin rash and kidney problems.

Carla Mozée   


Business Insider Latest Story Image
2 mins read

Moderna, BioNTech plunge as Bernie Sanders slams 'obscene' profits and tells drug makers to share COVID-19 vaccines with the world

"It's time for these pharmaceutical companies to share their vaccines with the world and start cont…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Moderna soars 6% as it begins vaccine testing in babies and children

Moderna and Johnson & Johnson's vaccines are approved for adults over 18, while the vaccine from Pf…

Isabelle Lee